The use of anthrax as a bioweapon is rare, but devastating. This new treatment might one day save people that are beyond the ...
Inflammation and coagulation are closely linked in sepsis. Inflammatory mediators generate tissue factor expression and initiate coagulation through activation of the extrinsic pathway ...
Sobi announces a new research collaboration on the development of Gamifant in sepsis, which is to be presented at the ISICEM congress: Stockholm Thursday, March 20, 2025, 12:00 Hr ...
Sepsis is one of the deadliest conditions in intensive care units (ICUs), triggered by the body's out-of-control response to infection. Despite medical advancements, its in-hospital mortality rate ...
The EMBRACE phase 2a trial (NCT06694701) was approved in March 2025. The first trial sites have been initiated, and patient screening to identify eligible patients with IDS has started. The EMBRACE ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results